DIA: Driving Insights to Action
autor: DIA
Najnowszy odcinek
DIA/Tufts CSDD Research: AI Saving Time in Drug Development
DIA/Tufts CSDD Research: AI Saving Time in Drug Development
O tym podcaście
DIA is a global, multidisciplinary, membership association of healthcare professionals that works towards the advancement of lifesaving medicines, therapies, and technologies around the world.
Odcinki
- DIA/Tufts CSDD Research: AI Saving Time in Drug Development · 11 min · Odcinek 200DIA and the Tufts Center for the Study of Drug Development (Tufts CSDD), in collaboration with 16 biopharmaceutical companies and CROs, conducted a study to map current use of…
- DIA: Your Partner in Life Sciences Training and Development · 14 min · Odcinek 199This podcast by the Drug Information Association (DIA) highlights the significant benefits of investing in professional development programs for employees in the life sciences…
- DIA: Going Beyond the Traditional Definition of Drug Development · 2 min · Odcinek 198In this DIA 60th anniversary interview, former Board President Ling Su shares his thoughts on the two most important aspects of DIA’s future for the next generation of members.
- GPP Experts Explain Authorship Algorithm · 8 min · Odcinek 197Good Publication Practice (GPP) experts explain the authorship algorithm designed to weigh each author's contribution relative to other authors' contributions in a study, and to…
- "Dossier in the Cloud" Democratizing Global Access · 3 min · Odcinek 196Accumulus Synergy CEO Francisco Nogueira shares expectations for the outcomes of a post-approval changes pilot led by Roche which utilizes the Accumulus platform and follows WHO…
- DIA: A Place Where You Can Make a Difference · 2 min · Odcinek 195Listen to former DIA Board President Minnie Baylor-Henry’s special message to DIA members as part of DIA’s 60th Anniversary celebration in 2024.
- Autumn’s Leukemia Story: Regimens, Recovery, and Realizations · 20 min · Odcinek 194A few years ago, 8-year-old Autumn noticed a lump on the side of her neck as she was preparing for bed one night. That quiet night opened a new chapter not only in Autumn’s life…
- Retiring TGA Head Maps Australia’s Post-Pandemic Future · 18 min · Odcinek 193In April 2023, Professor John Skerritt retired after 11 years of exemplary public service as deputy secretary of the Health Products Regulation Group and head of the Therapeutic…
- Patient Engagement: Evolution of Who Knows What, Part 2 · 14 min · Odcinek 192In part two of this podcast, “ePatients” Dave deBronkart and Stacy Hurt (Patient Advocacy Ambassador, Parexel) discuss new opportunities in the future of patient engagement in…
- Patient Engagement: Evolution of Who Knows What, Part 1 · 18 min · Odcinek 191DIA GAM 2023 Patient Engagement track chair Pujita Vaidya discusses the definition, history, and current state of patient engagement in clinical research and care with cancer…
- Australian Clinical Trials Alliance Part 2 – Future Projections · 15 min · Odcinek 190“Healthcare systems obviously have as their primary role the delivery of healthcare,” says Steve Webb, Australian Clinical Trials Alliance board chair. “But we can see big…
- ANVISA Explains Innovative Online Optimized Assessment Project · 15 min · Odcinek 189For regulators in Brazil, the pandemic’s aftermath includes a backlog of post-approval changes, delayed by emergency development of COVID-19 vaccines and therapies, related to…
- Australian Clinical Trials Alliance Part 1 – Current Perceptions · 13 min · Odcinek 188“The pandemic had a substantial impact on community understanding of clinical trials. Having said that, the sort of ambient level of community knowledge of clinical trials is…
- Looking Back and Ahead: Translational Science Advances Impacting Patient Care · 29 min · Odcinek 187From microphysiological systems and digital pathology to next-generation-sequencing and diversity in foundational genomic data sets: In this iteration of our annual year in…
- Rwanda Welcomes African Medicines Agency Home · 43 min · Odcinek 186While the African Medicines Agency (AMA) plans and plants its inaugural headquarters in Rwanda, the European Commission, the European Medicines Agency (EMA), several EU Member…
- Will Technology Solve the Research “People Problem”? · 20 min · Odcinek 185Clinical trials struggle to enroll eligible patients, while interested patients have difficulty finding pertinent clinical trials. Can technology help solve this people problem?…
- Why Trans/Nonbinary Research Benefits All Communities · 35 min · Odcinek 184Actions to increase patient diversity in clinical research initially addressed racial and ethnic demographics but are expanding to address gender identity. “Further research can…
- Digital Revolutionizing Data-Driven Reimbursement · 27 min · Odcinek 183Digital technologies are rippling through clinical research and care, promising deeper links between healthcare research and delivery. In her interview with Global Forum US…
- China Sets New Record for Local Drug Approvals in 2021 · 17 min · Odcinek 182DIA Global Forum’s annual review of new drug approvals in China has shown growth in both the number and types of new drugs approved in China from 2019 through 2021: from 34 new…
- WHO Pilot Formalizes CSA Process to Assist Developers · 15 min · Odcinek 181The World Health Organization has initiated a pilot coordinated scientific advice (CSA) procedure whereby product developers may obtain WHO advice on the most appropriate way to…








